A few days ago, the stock market in the United States fell to its lowest level since 1997 and markets around the world have been falling all year. So it is perhaps counterintuitive for Next Wave to train its focus on the careers of those involved in the commercialization of science. However, as Next Wave's editors around the world found out, this work continues apace and has in fact taken on a renewed urgency and importance in the face of dwindling financial resources.
Our essayists--many of them Ph.D. scientists--provide insider views on the processes and skills that they acquired in the lab but now use to identify and promote those discoveries that are likely to turn into marketable products and services. From their stories we learn that a scientist has much in common with an investor. Each has a specific expertise to contribute; each has much to learn about the other. And for those young scientists that are looking over the top of a crowded lab bench, their stories illustrate that the opportunities in this arena are varied, exciting, and challenging.
A Biologist in Venture Capital
Harjeet Sandhu  moved from the lab into financing start-ups in Germany; it's been a fun ride and all the indications are that demand will be high as the market matures.
Predicting a Future in Venture Capital
Jane Andrews , writing from Australia, has found that the transition from postdoctoral research to venture capital can open up myriad other career choices.
Getting It Off the Bench
Nicole Porter , an assistant technology manager with the University of Toronto's Innovations Foundation, writes about her transition from doing science at the bench to taking bench science to industry.
Scientists in Venture Capital Industries
Thanabalasingam Yugarani  provides an overview of venture capital industries in Singapore and profiles several scientists leading the way as entrepreneurs.
Creating and Exploiting Intellectual Property
Alexandra Bach  offers a first-hand account of life as a manager at a company dedicated to creating, developing, and exploiting intellectual property.
Scientists Moving Into the Tech-Transfer World
Jen McCormick  manages a commercialization initiative at the University of Michigan that facilitates interactions among faculty members, investors, and strategic and business consultants.
The Business of Biotechnology
Combining her interests in business and biology, Julia Schüler  is now responsible for all the marketing and thought leadership activities of Ernst & Young's Health Sciences/Biotech Team in Germany.
A Scientist on the Dark Side
Peter Kolchinsky  writes about his experiences breaking into the business side of science and his work at Massachusetts-based RA Capital Associates, where he evaluates biotech startups.
From Conception to Commercialization
Before you dive right in, John Higuchi , who manages start-up business ventures in the medical device and biopharmaceutical industries, suggests that you assess the potential of moving your idea from academic concept to profitable enterprise.
Breaking Into Technology Transfer
Helen Latham  believes that technology transfer, despite being overshadowed in the public mind by its more glamorous cousins "venture capital" and "business development," actually forms the pipeline through which university scientific research flows into the commercial arena.
Investing in Postdoctoral Research
Postdoc Network Editor Laure Haak  describes a partnership between the private sector and public institutions that hopes to enhance the quality of research at the selected universities by using generous stipends to attract outstanding postdocs.
Resources Our usual gathering of useful Internet resources, publications, and professional associations involved in the commercialization of science. Check it out !